The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 155-164 , January 2003

Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model

Received 3 December 2001 ,Revised 9 April 2002 ,Accepted 16 April 2002.

References 

  1. Karmazyn M, Moffat MP. Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox [review]. Cardiovasc Res. 1993;27:915–924
  2. Frölich O, Karmazyn M. The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc Res. 1997;36:138–148
  3. Avkiran M. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:10G–17G
  4. Pike MM, Luo CS, Clark MD, Kirk KA, Kitakaze M, Madden MC, et al.  NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na+-H+ exchange. Am J Physiol. 1993;265(6 Pt 2):H2017–H2026
  5. Xiao XH, Allen DG. Activity of the Na+/H+ exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res. 2000;48:244–253
  6. Opie LH. Postischemic stunning—the case for calcium as the ultimate culprit [review]. Cardiovasc Drugs Ther. 1991;5:895–899
  7. Kusuoka H, Porterfield JK, Weisman HF, Weisfeldt ML, Marban E. Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest. 1987;79:950–961
  8. Karmazyn M. Sodium-hydrogen exchange inhibition—a superior cardioprotective strategy. [editorial] J Thorac Cardiovasc Surg. 1996;112:776–777
  9. Scholz W, Albus U, Counillon L, Gogelein H, Lang HJ, Linz W, et al.  Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc Res. 1995;29:260–268
  10. Myers ML. Protection of the myocardium with sodium-hydrogen exchange inhibitors: a cardiac surgical perspective. J Thromb Thrombolysis. 1999;8:53–60
  11. Knight DR, Smith AL, Flynn DM, MacAndrew JT, Ellery SS, Kong JX, et al.  A novel sodium-hydrogen exchanger isoform-1 inhibitor, zoniporide, reduces ischemic myocardial injury in vitro and in vivo. J Pharmacol Exp Ther. 2001;297:254–259
  12. Gumina RJ, Buerger E, Eickmeier C, Moore J, Daemmgen J, Gross GJ. Inhibition of the Na+/H+ exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs. Circulation. 1999;100:2519–2526
  13. McDonough KH, Giaimo ME, Miller HI. Effects of endotoxin on the guinea pig heart response to ischemia reperfusion injury. Shock. 1995;4:139–142
  14. Gumina RJ, Mizumura T, Beier N, Schelling P, Schultz JJ, Gross GJ. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered. J Pharmacol Exp Ther. 1998;286:175–183
  15. Rohmann S, Weygandt H, Minck KO. Preischaemic as well as postischaemic application of a Na+/H+ exchange inhibitor reduces infarct size in pigs. Cardiovasc Res. 1995;30:945–951
  16. Jordan JE, Zhao ZQ, Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 1999;43:860–878
  17. Boyle EM, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997;63:277–284
  18. Choy IO, Schepkin VD, Budinger TF, Obayashi DY, Young JN, DeCampli WM. Effects of specific sodium/hydrogen exchange inhibitor during cardioplegic arrest. Ann Thorac Surg. 1997;64:94–99
  19. Myers ML, Karmazyn M. Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694. Ann Thorac Surg. 1996;61:1400–1406
  20. Theroux P, Chaitman BR, Danchin D, Erhardt L, Meinertz T, Schroeder JS, et al.  Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Circulation. 2000;102:3032–3038
  21. Thourani VH, Ronson RS, Van Wylen DG, Shearer ST, Katzmark SL, Zhao ZQ, et al.  Adenosine-supplemented blood cardioplegia attenuates postischemic dysfunction after severe regional ischemia. Circulation. 1999;100(19 Suppl):II376–II383
  22. Nakanishi K, Vinten-Johansen J, Lefer DJ, Zhao Z, Fowler WC, McGee DS, et al.  Intracoronary l-arginine during reperfusion improves endothelial function and reduces infarct size. Am J Physiol. 1992;263:H1650–H1658
  23. Zhao ZQ, Todd JC, Sato H, Ma XL, Vinten-Johansen J. Adenosine inhibition of neutrophil damage during reperfusion does not involve K(ATP)-channel activation. Am J Physiol. 1997;273(4 Pt 2):H1677–H1687
  24. Muraki S, Morris CD, Budde JM, Velez DA, Zhao ZQ, Guyton RA, et al.  Experimental off-pump coronary artery revascularization with adenosine enhanced reperfusion. J Thorac Cardiovasc Surg. 2001;121:570–579
  25. Maddaford TG, Pierce GN. Myocardial dysfunction is associated with activation of Na+/H+ exchange immediately during reperfusion. Am J Physiol. 1997;273(5 Pt 2):H2232–H2239
  26. Garcia-Dorado D, Gonzalez MA, Barrabes JA, Ruiz-Meana M, Solares J, Lidon RM, et al.  Prevention of ischemic rigor contracture during coronary occlusion by inhibition of Na+-H+ exchange. Cardiovasc Res. 1997;35:80–89
  27. Klein HH, Pich S, Bohle RM, Wollenweber J, Nebendahl K. Myocardial protection by Na+-H+ exchange inhibition in ischemic, reperfused porcine hearts. Circulation. 1995;92:912–917
  28. Yasutake M, Ibuki C, Hearse DJ, Avkiran M. Na+/H+ exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol. 1994;267(6 Pt 2):H2430–H2440
  29. Humphreys RA, Haist JV, Chakrabarti S, Feng Q, Arnold JM, Karmazyn M. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion. Am J Physiol. 1999;276(2 Pt 2):H749–H757
  30. Chakrabarti S, Hoque AN, Karmazyn M. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). J Mol Cell Cardiol. 1997;29:3169–3174
  31. Yamauchi T, Ichikawa H, Sawa Y, Fukushima N, Kagisaki K, Maeda K, et al.  The contribution of Na+/H+ exchange to ischemia-reperfusion injury after hypothermic cardioplegic arrest. Ann Thorac Surg. 1997;63:1107–1112
  32. Hendrikx M, Mubagwa K, Verdonck F, Overloop K, Van Hecke P, Vanstapel F, et al.  New Na(+)-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart. Circulation. 1994;89:2787–2798
  33. Klein HH, Pich S, Bohle RM, Lindert-Heimberg S, Nebendahl K. Na+/H+ exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow. Circulation. 2000;102:1977–1982
  34. Martin J, Sarai K, Yoshitake M, Haberstroh J, Takahashi N, Lutter G, et al.  Orthotopic transplantation of pig hearts harvested after 30 min of normothermic ischemia: controlled reperfusion with blood cardioplegia containing the Na+-H+-exchange inhibitor HOE 642. Eur J Cardiothorac Surg. 1998;14:607–614
  35. Gumina RJ, Auchampach JA, Wang R, Buerger E, Eickmeier C, Moore J, et al.  Na+/H+ exchange inhibition-induced cardioprotection in dogs: effects on neutrophils versus cardiomyocytes. Am J Physiol Heart Circ Physiol. 2000;279:H1563–H1570
  36. Fliegel L, Dyck JR. Molecular biology of the cardiac sodium/hydrogen exchanger. Cardiovasc Res. 1995;29:155–159
  37. Grace AA, Kirschenlohr HL, Metcalfe JC, Smith GA, Weissberg PL, Cragoe EJ, et al.  Regulation of intracellular pH in the perfused heart by external HCO3− and Na(+)-H+ exchange. Am J Physiol. 1993;265(1 Pt 2):H289–H298
  38. Stromer H, de Groot MC, Horn M, Faul C, Leupold A, Morgan JP, et al.  Na(+)/H(+) exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca(2+) overload and prolonged acidosis on reperfusion. Circulation. 2000;101:2749–2755
  39. Linz W, Albus U, Crause P, Jung W, Weichert A, Scholkens BA, et al.  Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642). Clin Exp Hypertens. 1998;20:733–749

☆ Supported in part by a Scientific Development Award (Z.Z.) and a Grant-in-Aid (J.V-J.) from the National American Heart Association. Cariporide was kindly donated by Aventis Pharma AG, Frankfurt am Main, Germany.

☆☆ Address for reprints: Jakob Vinten-Johansen, MD, Cardiothoracic Research Laboratory, Carlyle Fraser Heart Center, 550 Peachtree St, NE, Atlanta, GA 30308-2225 (E-mail: jvinten@emory.edu).

★ 0022-5223/2003 $30.00+0

PII: S0022-5223(02)73312-6

doi: 10.1067/mtc.2003.65

The Journal of Thoracic and Cardiovascular Surgery
Volume 125, Issue 1 , Pages 155-164 , January 2003

Article Tools

* Image Usage & Resolution